AKT1 and non-small cell lung carcinoma: Our results assemble with the findings of Wang et al. in which TB alleviates non-small cells lung cancer through the inhibition of the PI3K/Akt pathway and reduction of mTOR and cyclin D1 to achieve apoptosis, autophagy, and cell cycle arrest [17].